Compare PLRX & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLRX | CYH |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | United States | United States |
| Employees | 49 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.7M | 411.7M |
| IPO Year | 2020 | 2000 |
| Metric | PLRX | CYH |
|---|---|---|
| Price | $1.08 | $2.94 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 6 |
| Target Price | $2.67 | ★ $3.28 |
| AVG Volume (30 Days) | 360.5K | ★ 954.0K |
| Earning Date | 05-06-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.97 | ★ 196.67 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $12,485,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.17 |
| P/E Ratio | ★ N/A | $32.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.02 | $2.41 |
| 52 Week High | $1.95 | $4.43 |
| Indicator | PLRX | CYH |
|---|---|---|
| Relative Strength Index (RSI) | 43.14 | 48.15 |
| Support Level | $1.02 | $2.73 |
| Resistance Level | $1.37 | $3.00 |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 9.09 | 45.00 |
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.